Antineoplastic drugs, also known as anticancer drugs, anti-malignant drugs, refer to drugs for the treatment of malignant tumors.
Simply put, there are chemotherapy drugs and biological agents. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of tumors; the invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry, and genetic engineering have accelerated the process of drug development; research and development of anti-tumor drugs have been Enter a new era.
At present, there are more than 80 kinds of anti-cancer drugs commonly used in clinical practice in the world, which can be roughly divided into the following 6 categories: cytotoxic drugs, hormone drugs, biological response modifiers, monoclonal antibody drugs, other drugs, and auxiliary drugs.
The global Anticancer Drugs market is valued at 89300 million US$ in 2020 and will reach 163400 million US$ by the end of 2026, growing at a CAGR of 7.9% during 2021-2026. The objectives of this study are to define, segment, and project the size of the Anticancer Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Anticancer Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anticancer Drugs in these regions.
This research report categorizes the global Anticancer Drugs market by top players/brands, region, type and end user. This report also studies the global Anticancer Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
This report covers the present status and the future prospects of the global Anticancer Drugs market for 2015-2026.
The report offers detailed coverage of Anticancer Drugs industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Anticancer Drugs by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Cytotoxic Drugs (Alkylating Agents, and Antimetabolites), Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors), Hormonal Drugs,
Market Segment as follows:
Market by Order Type
Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
Hormonal Drugs
Market size by End User
Lung Cancer
Breast Cancer
Leukemia
Colorectal Cancer
market while maintaining their competitive edge over their competitors. The report offers detailed and crucial information to understand the overall market scenario.
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Anticancer Drugs market for the forecast period 2021 - 2026?
• What are the driving forces in the Anticancer Drugs market for the forecast period 2021 - 2026?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Anticancer Drugs industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.